Tartrate Resistant Acid Phosphatase Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIPA5116970-Each-of-1 | In Stock | ₹ 45,968.50 |
PIPA5116970 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 45,968.50
GST (18%): ₹ 8,274.33
Total Price: ₹ 54,242.83
Antigen
Tartrate Resistant Acid Phosphatase
Classification
Polyclonal
Conjugate
Unconjugated
Gene
ACP5
Gene Alias
acid phosphatase 5, tartrate resistant; acid phosphatase type V; Acp5; HPAP; human purple acid phosphatase; T5ap; Tartrate-resistant acid ATPase; tartrate-resistant acid phosphatase 5a; tartrate-resistant acid phosphatase 5b; tartrate-resistant acid phosphatase type 5; TRACP; TRACP5a; TRACP5b; TRAP; TR-AP; TRAPase; TrATPase; TTRRAP; Type 5 acid phosphatase
Host Species
Rabbit
Purification Method
Affinity chromatography
Regulatory Status
RUO
Gene ID (Entrez)
25732, 54
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Applications
Immunocytochemistry, Immunohistochemistry (Paraffin), Western Blot
Concentration
1.62 mg/mL
Formulation
PBS with 50% glycerol and 0.01% thimerosal; pH 7.3
Gene Accession No.
P13686, P29288
Gene Symbols
ACP5
Immunogen
Recombinant fusion protein containing a sequence corresponding to amino acids 76-325 of human ACP5 (NP_0016021)
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human, Rat
Product Type
Antibody
Isotype
IgG
Related Products
Description
- Positive Samples: BT-474, Jurkat Immunogen sequence: TGVQDINDKR FQETFEDVFS DRSLRKVPWY VLAGNHDHLG NVSAQIAYSK ISKRWNFPSP FYRLHFKIPQ TNVSVAIFML DTVTLCGNSD DFLSQQPERP RDVKLARTQL SWLKKQLAAA REDYVLVAGH YPVWSIAEHG PTHCLVKQLR PLLATYGVTA YLCGHDHNLQ YLQDENGVGY VLSGAGNFMD PSKRHQRKVP NGYLRFHYGT EDSLGGFAYV EISSKEMTVT YIEASGKSLF KTRLPRRARP Tartrate-resistant acid phosphatase (TRAP) is a basic iron-binding protein with high activity towards phosphoproteins, ATP and 4-nitrophenyl phosphatase
- It is detected in human alveolar macrophages, osteoclasts, spleen and liver
- Its expression is increased in spleen and monocytes of patients with Gaucher's disease; spleenocytes and circulating leukocytes of patients with hairy cell leukemia; spleen of patients with Hodgkin's lymphoma and in the sera of patients undergoing active bone turnover.